Search Results
You are looking at 1 - 1 of 1 items for
- Author: Anna-Maree Axell x
- Refine by access: All content x
Search for other papers by Helen E MacLean in
Google Scholar
PubMed
Search for other papers by Alison J Moore in
Google Scholar
PubMed
Search for other papers by Stephen A Sastra in
Google Scholar
PubMed
Search for other papers by Howard A Morris in
Google Scholar
PubMed
Department of Medicine, Hanson Institute, Department of Endocrinology, ANZAC Research Institute, University of Melbourne, Austin Health, Heidelberg, Victoria 3084, Australia
Search for other papers by Ali Ghasem-Zadeh in
Google Scholar
PubMed
Search for other papers by Kesha Rana in
Google Scholar
PubMed
Search for other papers by Anna-Maree Axell in
Google Scholar
PubMed
Search for other papers by Amanda J Notini in
Google Scholar
PubMed
Search for other papers by David J Handelsman in
Google Scholar
PubMed
Department of Medicine, Hanson Institute, Department of Endocrinology, ANZAC Research Institute, University of Melbourne, Austin Health, Heidelberg, Victoria 3084, Australia
Search for other papers by Ego Seeman in
Google Scholar
PubMed
Search for other papers by Jeffrey D Zajac in
Google Scholar
PubMed
Search for other papers by Rachel A Davey in
Google Scholar
PubMed
We used our genomic androgen receptor (AR) knockout (ARKO) mouse model, in which the AR is unable to bind DNA to: 1) document gender differences between males and females; 2) identify the genomic (DNA-binding-dependent) AR-mediated actions in males; 3) determine the contribution of genomic AR-mediated actions to these gender differences; and 4) identify physiological genomic AR-mediated actions in females. At 9 weeks of age, control males had higher body, heart and kidney mass, lower spleen mass, and longer and larger bones compared to control females. Compared to control males, ARKO males had lower body and kidney mass, higher splenic mass, and reductions in cortical and trabecular bone. Deletion of the AR in ARKO males abolished the gender differences in heart and cortical bone. Compared with control females, ARKO females had normal body weight, but 14% lower heart mass and heart weight/body weight ratio. Relative kidney mass was also reduced, and relative spleen mass was increased. ARKO females had a significant reduction in cortical bone growth and changes in trabecular architecture, although with no net change in trabecular bone volume. In conclusion, we have shown that androgens acting via the genomic AR signaling pathway mediate, at least in part, the gender differences in body mass, heart, kidney, spleen, and bone, and play a physiological role in the regulation of cardiac, kidney and splenic size, cortical bone growth, and trabecular bone architecture in females.
